Drug Profile
GSK 070
Alternative Names: GSK 070Latest Information Update: 10 Jul 2023
Price :
$50
*
At a glance
- Originator Anacor Pharmaceuticals
- Developer Global Alliance for TB Drug Development; GSK; Pfizer
- Class Antituberculars
- Mechanism of Action Leucyl-tRNA synthetase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Tuberculosis